Section of Anaesthetics
The term 'hypersensitivity reaction' is used here to mean a reaction with some of the effects of histamine. The clinical signs, therefore, are similar whatever the drug causing them, and are distinguishable from the effects of an overdose of the particular drug. The commonest signs are: (1) cutaneous flushing, often with cedema (e.g. of the eyelids) and wheals; (2) cardiovascular collapse associated with vasodilatation and tachycardia;
(3) bronchospasm (or rarely laryngospasm); (4) abdominal pain. Fig 1 shows the incidence of published cases year by year since 1943, the year of Halford's paper on the Pearl Harbour disaster. Cutaneous reactions to barbiturates were first reported by Hunter in 1941 and there were many subsequent reports of dermatitis and photosensitivity. However, generalized reactions were not seen for the first twenty years after the introduction of thiopentone, until Hayward & Kiester (1957) reported the first conclusive case of idiosyncracy. Over the next seventeen years 14 cases were reported in the literature, and in our study (Clarke et al. 1975 ) a further 12 cases are listed. Interest was also stimulated by the reports of reactions to propanidid from 1965, and of reactions to Althesin (CT 1341) from 1973. It would seem that these reactions are not due to any one drug. The increasing frequency of the reactions is probably part of a generalized increase in all hypersensitivity reactions associated with a greater intake of all drugs by the population. Also, with any one drug the number of repeat administrations in a population must rise. Harrfeldt (1973) , working in West Germany, had no reactions with propanidid in the first 35 000 administrations but 4 in the next 45 000.
Our experience has shown that once interest in a particular hypersensitivity reaction is generated the frequency of subsequent reports increases. Several factors, therefore, are probably involved. To summarize our findings in 100 reported hypersensitivity reactions (Clarke et al. 1975 ): 10 were deleted as due to the poor health of the patient, and 4 as due to the muscle relaxant, leaving 86 attributable to the anmsthetic. However, of these, as many as 30 have been caused by either pancuronium or suxamethonium. There is not enough evidence for certainty, but the latter is increasingly being found responsible for such reactions.
The reactions were broken down as follows: (1) Histaminoid (19 cases) was used to describe reactions typical of massive histamine release in man.
(2) Histaminoid with bronchospasm (33 * Not all patients were questioned about these points cases) was a commoner classification, and included patients with marked production of mucus, violent coughing or laryngospasm. The only deaths judged to have been caused by the anesthetic are in this group and all 4 occurred after the use of thiopentone.
(3) Bronchospasm (12 cases) which occurred without accompanying cardiovascular effects. Cases were only accepted if they occurred before tracheal intubation. (4) Cardiovascular collapse (16 cases) was the term we used to describe acute hypotension without flushing and usually with facial pallor. All the instances of reaction to propanidid (Epontol) occurred in this group. (5) Delayed histaminoid reactions (6 cases) covered those with a 12-80 minute interval before the histaminoid phenomena. The frequency of report here does not of course give any indication of incidence. Reports with propanidid (Epontol) were few because the drug usage had diminished in the UK even by 1973-75. Reports with Althesin (CT 1341) were many because it was topical and Glaxo Laboratories had initiated the investigation. Some reported figures of the incidence of anaphylactic reactions to intravenous anesthetics are as follows: (a) Propanidid: Dannemann & Lubke (1970) (1976) 1 in 900. The incidence of reactions to thiopentone is probably even lower. However, the number of reported fatal reactions to Althesin still remains very low (1 or 2) whereas it is much higher with propanidid and even thiopentone.
Having discussed reported reactions we may well ask how we can identify a particular patient who is likely to have a reaction. In other words, what are the predisposing factors? Most of the patients included in the above study were questioned on the following points: (1) history of atopy (eczema, hay fever, asthma); (2) history of allergy to drugs, food &c.; (3) history of previous antesthetics, especially of having received the same drugs. However, the answers obtained are difficult to interpret unless we know how many of the typical surgical population (who have not reacted to anesthetics) give positive answers to these questions.
We therefore asked for the help of our colleagues throughout the British Isles in filling up questionnaires on a random selection of their patients. The present analysis is based on the first 5500 distributed between different surgical groups.
Atopy
The survey revealed an incidence of an atopic history in the surgical population of around 90% (Table 1) . This was similar to the incidence encountered in the patients who had had reactions, though all patients having reactions had not been questioned on this point. The figures could be broken down even further: for instance, 260% of the 31 patients reacting to thiopentone had a positive history of atopy, compared with none in the 49 patients reacting to propanidid. This could, however, be related to variations in questioning between different reported series. Allergy Allergy to penicillin is much the commonest, occurring in 7 %. Altogether, 14 % of the patients studied said that they were allergic to something. In patients having hypersensitivity reactions the figure was much higher. There was a highly significant difference between the number of patients giving a history of allergy in the present survey and all published reports of reactions (Z2 = 14.99; P<O0.00).
Previous Anasthetic
The survey revealed that as many as 660% of the surgical population have had a previous anesthetic. This is similar to the incidence in patients reacting to intravenous anesthetics. Unfortunately the questionnaire only revealed the actual drugs that had been given in a much smaller percentage, but there are some data by which to assess the patient's previous anesthetic history.
The following is a breakdown of the anesthetic histories (the figures for any one drug are clearly minimal estimates): no previous anesthetic 34; an anesthetic but drug not known 36; intravenous barbiturates previously 24; Althesin previously 5; other intravenous agents previously 4 (some patients of course had received more than one agent).
On analysing the patients with hypersensitivity the available data suggest that about 50 % had had the same drug previously. The percentage of patients in the survey who had received barbiturates previously is about half that in the patients reacting, but the evidence that previous exposure to barbiturates is a factor in hyper-sensitivity reactions to them must still be regarded as inconclusive. On the other hand, it may be that the previous exposure to barbiturates had been too long ago to leave residual sensitivity. However, only 5 % of the surgical population were known to have been exposed to Althesin previously, whereas in those reacting to Althesin approximately 50 % had been so exposed. This suggests that previous exposure to Althesin may be a causative factor in hypersensitivity reactions to this agent. In summary, these data suggest a positive association between a history of allergy and hypersensitivity reactions to anesthesia. There is slight evidence to suggest that previous exposure to barbiturates is relevant to reactions to thiopentone, but reactions to Althesin do occur more commonly in patients who have been exposed to Althesin than would be expected by chance.
